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Abstract 
This is an overview of the some of the most recent and 
seminal research done on Attention Deficit Hyperactivity 
Disorders (ADHD). ADHD is currently one of the most 
common reasons for referral to child mental health 
services and still is under-recognised both in children 
(5.29%) and adults (2.5%). ADHD is a highly heritable 
disorder with a mulitifactorial pattern of inheritance. 
Parents, siblings and parents of a child with ADHD are 4-5 
times more likely to have ADHD. Environmental factors 
also play a role in elucidating this disorder. Untreated 
ADHD leads to numerous co-morbidities, and longer term 
morbidity. Methylphenidate is suggested as the first line 
pharmacological treatment. ADHD is easy to treat, 80% of 
correctly diagnosed patients (children or adults) respond 
favourably to methylphenidate. All child and general adult 
psychiatrists should be aware of this disorder, comfortable 
with making the diagnosis and treating adults with ADHD. 
The purpose of the overview is to cover the epidemiology, 
aetiology, diagnostic criteria and different managements of 
ADHD. 
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Introduction 
Attention deficit hyperactivity disorder (ADHD) 
is a neurodevelopmental disorder. It is characterised 
by persistent symptoms of inattention, hyperactivity 
and impulsivity according to Diagnostic and Statistical 
Manual of Mental Disorders 4
th
 edition (DSM IV)
1
 or 
classed under the term hyperkinetic disorder in the 
International Classification of Diseases 10
th
 edition 
(ICD10) with  characteristics including early onset, 
disorganized , ill-regulated, and excessive activity, 
recklessness and impulsivity
2
. ADHD is markedly 
more prevalent in males than females
3
. However the 
ratio changes depending on the population studies, (the 
ratio ranges between 9:1 and 2.5:1). By definition, the 
onset of hyperkinetic disorder must be present in at 
least two out of three environments (home, school, 
clinic), this behaviour must be maladaptive and 
pervasive. The onset of hyperkinetic disorder is before 
the age of 7 years, but is frequently recognised in 
children less than 2 years old
4
. DSM V is proposing to 
keep ADHD as one of its disorders. The main 
proposed change is around broadening the age of onset 
“on and before age 12”.5 
The aim of this paper is to bring together some of 
the seminal, recent studies on ADHD published and 
found on the main databases (these include; Embase, 
Medline, Web of knowledge, Ovid, Scopus). With the 
aim of providing the reader with a clear concise 
overview of this common disorder. The epidemiology, 
aetiology, diagnostic criteria and management for both 
children and adults suffering from ADHD will be 
elucidated below (Table 1). 
 
Epidemiology 
The prevalence of ADHD varies from one study 
and country to another. In childhood, the prevalence of 
ADHD in the UK is estimated at 2.23 % age 5-15.
6
 
Whilst in the United States, the National Health 
Interview Survey (NHIS)(2006) estimated the 
prevalence of ADHD among children age 3-17 to be 
7 %.
7
 In adulthood, the worldwide prevalence of 
ADHD was found to be 5.29% 
8 
with minor 
differences between countries. Studies report that these 
values are actually underestimates of the true 
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prevalence of ADHD, stating that this disorder is under-
identified and treated in only a minority or cases.
9
 Cases 
are not being identified because young people are not 
brought forward to mental services (reason being; 
believing ADHD is not a disorder and/or the behaviours 
are self-limiting and/or the stigma attached to mental 
health). In adults recall bias effects the accuracy of the 
actual prevalence of ADHD.
6,7,8,9
 ADHD is more 
common in younger children, urban more than rural 
communities and low socio-economic status.
9
 
 
 
Symptoms Groups 
Inattention  
Does not attend  
Fails to finish tasks 
Cannot organize 
Avoids sustained effort 
Loses things 
Forgetful 
Easily distracted 
Does not listen 
Hyperactivity  
Fidgets  
Leaves seat in class  
Runs/climbs excessively 
Cannot play/work quietly 
Always “on the go” 
 
Impulsivity  
Talks excessively  
Blurts out answers  
Cannot await turn 
Interrupts others 
Intrudes on others 
Blurts out answers 
 
DSM-IV ADHD ICD-10 HKD 
Symptoms  
Either or both of the following: 
 At least six of nine inattentive symptoms 
 At least six of nine hyperactive or impulsive 
symptoms 
All of the following: 
 At least six of eight inattentive symptoms 
 At least three of five hyperactive 
symptoms 
 At least one of four impulsive symptoms  
Pervasiveness  
Criteria are met in one situation and impairment is present in another 
Criteria are met in more than one situation 
 
   Table 1: ADHD diagnostic criteria 
 
 
Aetiology 
Genetic studies on ADHD indicate high heritability 
(this is a term used in twin studies to calculate the 
difference in concordance rates between monozygous and 
dizygous twins, the higher the hereditability rate the higher 
is the genetic contribution to a phenotype). In the case of 
ADHD the hereditability is estimated as high as 76% and 
so is genetic linkage high, indicating that there is a high 
genetic contribution which gives rise to this disorder.
4
 
Genetic studies report that there is no one gene that codes 
for ADHD. Whole genome linkage studies suggest there 
are no common susceptibility genes but multiple genes of 
small effect size that interact with the environmental risk.
10
 
Family studies show that the prevalence in children of 
adults suffering from ADHD is 57%. Parents and siblings 
of a child with ADHD are 4-5 times more likely to have 
ADHD than the general population.
4
  
The neurobiology of ADHD suggests its association 
with cognitive processing deficit
3
 and the pathophysiology 
is strongly linked to dopamine and norepinephrine 
neurotransmitter systems. Rutter in 2006 indicated that the 
main problem lies in “behavioural dysregulation, executive 
deficits in inhibitory control, working memory, and delay 
aversion.”3 The hypofrontality theory suggests that 
ADHD is associated with subnormal activation of the 
prefrontal systems responsible for higher-order motor 
control. 
Paediatric neuroimaging studies showed reduced 
amygdala volumes and bilateral increase in 
hippocampus volumes.
11
 Poor functioning in the 
striatum, frontal lobes, and posterior periventricular 
regions are indicated in attention problems.
12
 
Biological based phenotypes that lie in the 
pathway from genes to behaviour may provide insight 
into this link, an example of these are endophenotypes. 
Endophenotypes are measurable components unseen 
by the unaided eye found along the pathway between 
disease and distal genotype. They may be 
neuroanatomical, cognitive, neurophysiological, 
biochemical or endocrinological in nature which 
represent simpler clues to genetic underpinnings than 
the disease syndrome itself. These endophenotypes 
serve to promote the view that a psychiatric disorder 
can be deconstructed; thus enabling more 
straightforward genetic analysis. These endophentpyes 
must be associated with a candidate gene or gene 
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region. Such endophenotpes have aided the clarification of 
aetiology of several  neurodevelopmental disorders such as 
autism. Neuropsychological impairments, neuroimaging 
and electrophysiological paradigms for ADHD show 
potential to move molecular genetics research forward. 
The recognition of a specific ADHD ‘endophenotype’ 
would help identify individuals that are ‘at risk’ of 
developing ADHD and this could help reduce this high 
rate of disability associated with this disorder.
13
 
Environmental factors also play a role in the 
development of ADHD. Obstetric complications
14
 and 
extremely low birth weight (less than 1000g).
15
 are linked 
to attentional difficulties. Exposure to lead, often through 
lead water pipes in old houses, and head trauma 
particularly implicating the frontal cortex famously in the 
case of Phineas Gage
16
 can lead to cognitive effects 
mimicking ADHD. Similarly, it appears that some children 
benefit from hypoallergenic foods, which suggests that, 
although the mechanism is not clear, certain dietary 
elements can contribute to symptoms.
17
 It is important to 
note that environmental risks need to be present during a 
critical period so as to have an effect on outcome.  
 
Over the last decade there has been a vast increase in 
the knowledge on brain development and severe 
deprivation in infancy (in the form of neglect and/or 
abuse) which leads to attachment disruption having lasting 
developmental effects. It has been demonstrated that the 
establishment of synaptic connections between neurons 
and the programming of the neurochemical responses that 
have an effect on the development of the whole body are 
dependent on experience. The most sensitive period for 
brain growth and optimal plasticity, is over the first 3 years 
of life.
18
 Through stress and misattunement of this 
relationship the child’s neurodevelopment is halted, this 
reduces the child’s ability to self-regulate affect and the 
child may present with symptoms which mimic ADHD 
symptomatology.
19
 
  
The concept of ADHD 
The diagnosis of ADHD in children has been a 
controversial issue for many years, some arguing that it did 
not exist and whilst others reporting the contrary. The 
validity of a diagnosis of ADHD in pre-school children has 
also increased over the years; these present with the same 
symptom structure
20
, similar neuropsychological deficits, 
associated impairment, co-morbidity and developmental 
risk.
20
 
The scepticism about adult ADHD is influenced by the 
absence of well validated and universally accepted 
diagnostic criteria. Also the retrospective diagnosis of 
adult ADHD is significantly biased by current level of 
functioning.
21
 
 
Adult ADHD 
ADHD diagnosed in childhood tracks on through 
to adulthood, with 4-15% retain full diagnosis and 50-
66% in partial remission.
22
 A recent meta-analysis 
reported; the overall pooled prevalence rate for adult 
ADHD is 2.5%.
23
 Many aspects play a role in the 
estimation of prevalence adult ADHD. Children do not 
outgrow the disorder but the diagnostic criteria. 
Meaning this actually is an underestimation of the true 
prevalence of the disorder.  
 
Why should adult mental health services be 
interested in ADHD?  
ADHD is a common behavioural disorder that is 
associated with significant adult psychopathology, 
social and academic impairments.  In many cases 
ADHD symptoms persist into adult life and cause 
significant clinical impairments.
22
 
 
Clinical presentation in adults 
When looking to diagnose adults with ADHD, it is 
important to keep in mind that hyperactivity is a less 
prominent symptom when compared to inattention and 
impulsivity. Adults are more often disabled by their 
poor concentration (having ceaseless mental activity or 
a distracted mind) affecting their daily function, this 
intern may result in low self-esteem, variable 
performance at work and low mood.
24
 
Adults with ADHD prefer occupations that are 
exciting and busy and have an element of risk (e.g. 
stock broking, entrepreneurial ventures), undergo 
frequent changes in employment, have poor planning 
abilities (e.g. organizing finances, handling course 
work), messiness, dangerous driving, unstable 
relationships, and engagement in leisure activities that 
are highly absorbing or stimulating (e.g. downhill 
skiing, high-contact sports). Adults usually have 
difficulty organizing their homes (e.g., cooking regular 
meals, cleaning) and managing their children (e.g. 
packing their lunches, getting to appointments on 
time).
25
  
 
Psychiatric comorbidity 
Comorbidity is not uncommon in adults with 
ADHD. Studies report high rates of antisocial 
personality disorders with poorer prognosis
3
, (rates 
vary from 12% to 23%). Other comorbidities include: 
high rate of substance abuse
3
, depression, anxiety and 
bipolar disorder
26
, Oppositional Defiant Disorder, 
Conduct disorder
 
and aggression probably as a result 
of affective disorders (Figure 1).
 
 
 
Management 
The first step in management is making an 
accurate diagnosis, using a multimodel assessment 
  
 
Review Article 
 
 
 
 
Malta Medical Journal    Volume 25 Issue 01 2013                                                                                                               5 
 
 
approach (this includes an indepth clinical psychiatry 
interview, a cognitive assessment by psychologist, school 
observation, ADHD nurse specialist assessment, clinical 
review of young person and physical examination, blood 
investigations, collateral history from parent or partner and 
questionnaires such as the Conner’s questionnaire are 
useful adjuncts.
26
 This multimodal assessment is brought 
together in a formulation meeting were a diagnosis 
decision takes place for both young people and adults. 
Management of ADHD must be delivered by a specialist 
in ADHD. In children, this involves passing on the 
appropriate information and advice to parents and child, 
informing the family doctor, school education and 
educational psychologist. In adults, the same approach 
should be adapted depending on the person circumstances 
and services/work/ education involved with the specific 
individual.
27
 
A combination of interventions plays a role in 
managing adults with ADHD these include; 
pharmacological, neuropsychological and 
environmental interventions.
12
 Methylphenidate is 
suggested as the first line pharmacological 
treatments.
26, 12
 Other common treatments include 
atomoxetine, and amphetamines.
26, 12
 However, other 
pharmacological treatments are used, but with less 
evidence: these include alpha-2 agonists (clonidine, 
bupropion, modafinil) and antidepressant with 
noradrenergic effects (imipramine and venlafaxine).
26
 
Parent training should be the first choice treatment 
for pre-school children presenting symptoms of 
ADHD. Medication is only introduced for those, 
where parent training has failed. The adverse events 
rate for methylphenidate in this age group is high 30% 
compared to <1% in older children.
28
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Figure 1: Co-morbidity in Dutch series of 141 adult ADHD cases
35 
78% of ADHD cases had one co-morbidity 
 
 
Pharmacological treatment 
Therapeutic effects of medication include 
improvements in ADHD symptoms, peer and family 
relationships, improved learning, self-esteem and social 
skills will be observed soon after started medication. 
Clinical monitoring involves: 
 Pre-treatment: plotting height and weight 
on a growth chart (children only), assessing motor 
coordination (children only) and a cardiovascular 
examination (children and adults). 
 During treatment: measurement of weight 
(children and adults), height (children), blood 
pressure and pulse (children and adults) 
27
, as well 
as monitoring side effects of the medication 
(children and adults). 
ADHD is easy to treat with 80% of correctly 
diagnosed patients responding to treatment. 
Stimulants (e.g. methylphenidate hydrochloride such 
as Ritalin) 
The use of psychomotor stimulants to treat the 
symptoms of ADHD goes back to 1937 when Bradley 
noticed a significant change in behaviour and 
improvement in school performance.
29
 
Methylphenidate is a central nervous system 
stimulant, it blocks the presynaptic membrane 
dopamine transporter and thereby inhibits the reuptake 
of dopamine and noradrenaline into the presynaptic 
neuron.
26
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There are two forms of Methylphenidate: immediate 
release and extended release. The extended-release form of 
methylphenidate was initially developed to address the 
issues of multiple dosing and compliance issues in children 
and adolescents. The extended release form such as 
(Metadate CD) comprise of both an immediate release 
component (30% of the dose) and extended release 
component (70% of the dose) or such as (Concerta) uses 
osmotic pressure to deliver methylphenidate hydrochloride 
at a controlled rate. 
Immediate release methylphenidate has some 
advantages in targeted situations such as important 
meetings/events or exams. While the advantages for the 
extended-release methylphenidate for adults are similar to 
those in children:  improvement of compliance and 
avoiding taking mediaction during education/employment 
hours. There is a potential for drug misuse or diversion, 
though research reports this is rare.
26
 
Non-stimulants 
Atomoxetine increases nor adrenaline and also 
dopamine in the prefrontal cortex. It  blocks noradrenaline 
reuptake pumps. Atomoxetine appears to be an efficacious 
treatment of adult ADHD. Its lack of abuse potential may 
be an advantage. The effect size reported is smaller than 
that of the stimulants
30
. 
 
 
Psychological treatment 
This includes making use of some of the following; 
cognitive-behavioural therapy, family therapy, social skills 
training.
24
 When using CBT and/or social skills training 
for the child or young person in conjunction with a parent 
training/education programme, particular emphasis should 
be given to targeting a range of areas, including social 
skills with peers, problem solving, self-control, listening 
skills and dealing with and expressing feelings. Active 
learning strategies should be used, and rewards given for 
achieving key elements of learning. For older adolescents 
with ADHD individual psychological interventions (such 
as CBT or social skills training) are advised as they are 
more effective and acceptable than group parent-
training/education programmes or group CBT and/or 
social skills training.
26
 
The current evidence for pre-school children 
demonstrates that there is good efficacy in reducing 
ADHD symptoms by parenting training. The three 
inventions with most evidence are: New forest parent 
training programme, the triple P-positive parenting 
programme
31
, and the incredible years training 
programme.
32
 The latter programme has the most research 
evidence for being effective. It is a form of group 
parent/child training, which involves focusing on child-
directed play, effective praise, handling separations, 
routines, limit setting and using positive discipline 
with distending/redirecting unwanted behaviour.
32 
 
Conclusions/key points 
ADHD is a common disorder which is probably 
under-recognised in mental health settings and the 
community. Prevalence estimated at 5.29% for 
children
9
 and 2.5% for adults with high heritability.
33
 
ADHD is best viewed as a gene-environment 
interaction. Currently there are two predominant 
theoretical models used to explain ADHD: first 
executive dysfunction underpinned by deficient 
inhibitory control mechanisms and second, delay 
aversion, underpinned by behaving impulsively in 
order to avoid delay. 
Comorbidity is prevalent in 30-70% of children 
and adults diagnosed with ADHD, this should be 
carefully considered when assessing people with 
ADHD.  
A multidisciplinary multimodal approach with 
specialists carrying out their individual assessments 
then bringing them all together in a formulation 
meeting, followed by clear reporting to child/adult 
care givers is key to accurate diagnosis of both 
children and adults. 
The management of ADHD should focus on 
pharmacological, psychological and environmental 
interventions, with methylphenidate being first line in 
adults but used only after parental training in pre-
school children
26
. ADHD is a disorder that is easy to 
treat with 80% of correctly diagnosed patients 
(children or adults) responding to treatment.
34
 
Awareness of ADHD is improving in the 
speciality of child and adolescent psychiatry but 
remains poor in general adult psychiatry. The authors 
suggest psychiatrists and clinicians access more 
training courses to help them be comfortable with 
making the diagnosis and treating ADHD. 
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